A Prospective Randomized Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS element) for the Treatment of up to Two De Novo Coronary Artery Lesions - PLATINUM Trial

ID Number 09-0201

Principal Investigator(s)
Annapoorna S Kini

Department(s) or Division(s)
Cardiology

Research Entity
Zena and Michael A. Wiener Cardiovascular Institute

Description

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Elementâ„¢ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. ClinicalTrials.gov Identifier: NCT00823212



Contact Information
Kameswari Vallabhajosyula
(212) 241-5696
kameswari.vallabhajosyula@msnyuhealth.org


Recruiting Patients: No